Welcome to LookChem.com Sign In|Join Free

CAS

  • or

19185-89-8

Post Buying Request

19185-89-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

19185-89-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 19185-89-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,1,8 and 5 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 19185-89:
(7*1)+(6*9)+(5*1)+(4*8)+(3*5)+(2*8)+(1*9)=138
138 % 10 = 8
So 19185-89-8 is a valid CAS Registry Number.

19185-89-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-methyl-2,3-dihydro-4H-pyran-4-one

1.2 Other means of identification

Product number -
Other names 2,3-dihydro-2-methyl-4-pyrone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:19185-89-8 SDS

19185-89-8Relevant articles and documents

HYDROXYL PURINE COMPOUNDS AND USE THEREOF

-

Paragraph 0164; 0165; 0166, (2018/06/09)

Disclosed are a series of hydroxyl purine compounds and the use thereof as PDE2 or TNFα inhibitors, in particular, the compounds as shown in formula (I), or tautomers or pharmaceutically acceptable salts thereof.

HEPATITIS C VIRUS INHIBITORS

-

Page/Page column 26-27, (2012/08/28)

The present disclosure relates to compounds of formula I, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in th

INHIBITORS OF SERINE PROTEASES

-

Page/Page column 303, (2010/11/26)

The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salt or mixtures thereof that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 19185-89-8